Question
Ended December 31 (in millions) 2018 2017 2016 Interest expense $(241) $(229) $(233) Weighted average borrowing rate 3.60% 3.80% 4.00% Cash paid for interest $(262)
Ended December 31 (in millions) | 2018 | 2017 | 2016 |
---|---|---|---|
Interest expense | $(241) | $(229) | $(233) |
Weighted average borrowing rate | 3.60% | 3.80% | 4.00% |
Cash paid for interest | $(262) | $(235) | $(233) |
The price of the Boston Scientifics bonds in February 2019 follows. Interpreting Debt Footnotes on Interest Rates and Interest Expense Boston Scientific discloses the following as part of its longterm debt footnote in its December 31, 2018 10K.
Borrowings and Credit Agreements | ||||||
---|---|---|---|---|---|---|
Semi- | ||||||
annual | ||||||
In millions, except | As of December 31, | Coupon | ||||
interest rates | Issuance Date | Maturity Date | 2018 | 2017 | Rate | |
January 2020 Notes | December 2009 | January 2020 | $850 | $850 | 6.00% | |
May 2020 Notes | May 2015 | May 2020 | 600 | 600 | 2.85% | |
May 2022 Notes | May 2015 | May 2022 | 500 | 500 | 3.38% | |
October 2023 Notes | August 2013 | October 2023 | 450 | 450 | 4.13% | |
May 2025 Notes | May 2015 | May 2025 | 750 | 750 | 3.85% | |
March 2028 Notes | February 2018 | March 2028 | 1,000 | 4.00% | ||
November 2035 Notes | November 2005 | November 2035 | 350 | 350 | 7.00% | |
January 2040 Notes | December 2009 | January 2040 | 300 | 300 | 7.38% | |
Unamortized debt insurance discount and deferred | ||||||
financing cost | 20202040 | (29) | (24) | |||
Unamortized gain on fair value hedge | 20202025 | 26 | 38 | |||
Capital lease obligation | Various | 6 | 1 | |||
Long-term debt | $4,803 | $3,815 |
(1) Corporate credit rating improvements may result in a decrease in the adjusted interest rate on our November 2035 Notes to the extent that our lowest credit rating is above BBB or Baa3. The interest rates on our November 2035 notes will be permanently reinstated to the issuance rate if the lowest credit ratings assigned to these senior notes is either A- or A3 or higher. Boston Scientific discloses its required principal debt repayments due during each of the next five years and thereafter.
In millions | |
---|---|
2019 | $2,136 |
2020 | 1,540 |
2021 | - |
2022 | 500 |
2023 | 450 |
Thereafter | 2,400 |
Boston Scientific also discloses the following information. Interest Expense The following table provides a summary of our Interest expense and average borrowing rate:
Moodys Rating | ||||
---|---|---|---|---|
Maturity date | Coupon | Current Price | Current Yield | (02/21/2019) |
2028 | 4.00% | 109.35 | 2.80% | Baa2 |
2023 | 4.13% | 101.57 | 2.41% | Baa2 |
Required b. What is the total amount of Boston Scientifics longterm debt at December 31, 2018, including the current maturities?
The answer is not 4803 or the sumation of all debts c. The companys balance sheet reports shortterm debt including current maturities of $2,140 million and $1,711 million in 2018 and 2017, respectively. Compute the average effective interest rate on the companys total debt for fiscal 2018. Compare this to the average interest rate the company reports. Note: Do not round until your final answer. Note: Round your final percentage answer to one decimal place (for example, enter 6.7% for 6.6555%).
Computed average effective interest rate | ? |
Company's reported average interest rate | 3.6 |
Step by Step Solution
There are 3 Steps involved in it
Step: 1
Get Instant Access to Expert-Tailored Solutions
See step-by-step solutions with expert insights and AI powered tools for academic success
Step: 2
Step: 3
Ace Your Homework with AI
Get the answers you need in no time with our AI-driven, step-by-step assistance
Get Started